What is the market's earnings forecast for Houlihan Lokey next quarter?

What guidance did Houlihan Lokey's management provide for the next earnings period?

What does Houlihan Lokey do and what are its main business segments?

What is Houlihan Lokey's gross profit margin?

What is Houlihan Lokey's latest dividend and current dividend yield?

Did Houlihan Lokey beat or miss consensus estimates last quarter?

What factors drove the changes in Houlihan Lokey's revenue and profit?

What is the revenue and EPS growth rate for Houlihan Lokey year over year?

- **Revenue Growth**: Q3 revenue up 13% YoY to $717M, driven by Corporate Finance (+12%) and Restructuring (+19%). 
- **European Expansion**: Acquired Mellum Capital's Real Estate Advisory business and 51% stake in Audere Partners (France). 
- **Restructuring Outlook**: Q3 was atypical peak; expect normalization in Q4 but long-term potential from geopolitical risks. 
- **Capital Allocation**: Focus on M&A (strong pipeline) with selective share buybacks. 
- **Market Position**: #1 global M&A and restructuring advisor, with accelerating middle-market deal flow. 


**【CEO Opening Remarks】**
- Q3 2026 revenue: $717 million (+13% YoY), Adjusted EPS: $1.94 (+18% YoY). 
- Corporate Finance revenue: $474M (+12% YoY), driven by higher fee rates and new business. 
- Financial Restructuring revenue: $156M (+19% YoY), outperforming expectations due to accelerated deal timelines. 
- Acquisitions: Real Estate Advisory business from Mellum Capital (11 new colleagues) and 51% stake in Audere Partners (France). 
- Outlook: FY2027 optimism due to improving M&A sentiment, private equity activity, and deal backlog visibility. 

**【CFO Financial Commentary】**
- Corporate Finance: 177 transactions (vs. 170 last year), avg fee increase. 
- Restructuring: 41 transactions (flat YoY), avg fee increase. 
- Advisory: 1,103 fee events (+10% YoY). 
- Expense management: 61.5% comp expense ratio (target range). 
- Share buybacks: 418,000 shares repurchased in Q3. 
- French acquisition: Expected to close in Q4 with 51% ownership. 

**【Q&A Highlights】**
1. **Restructuring Outlook**: 
   - Q3 was unusually strong, expecting normalization in Q4. 
   - Long-term outlook positive due to geopolitical risks, but near-term cautious. 
2. **Corporate Finance Growth**: 
   - Q4 likely similar to Q3, with FY2027 growth driven by private equity liquidity. 
   - U.S. remains largest market, but Europe (esp. France) shows strong momentum. 
3. **Capital Allocation**: 
   - Prioritize acquisitions (pipeline remains strong) over share buybacks. 
   - Q3 cash balance: $1.2B, supporting both M&A and buybacks. 
4. **Advisory Cycle**: 
   - In early innings of M&A recovery, with pent-up demand in middle market. 
   - Houlihan Lokey taking market share via subsector specialization and global expansion. 


Houlihan Lokey, Inc. (HLI) Q3 2026 Earnings Call Transcript

- **Revenue and EPS Growth**: $659M (+15% YoY), $1.84 EPS (+26% YoY), driven by 21% CF revenue rise.\n- **Backlog Momentum**: Q4 CF expected to outpace Q3, breaking seasonal trends.\n- **International Expansion**: EMEA/Asia revenue up 9.7% YoY, targeting Europe fee parity with U.S.\n- **Financial Health**: 61.5% comp expense ratio, $1.1B cash, 210K shares repurchased.\n- **Strategic Focus**: Active acquisition pipeline and talent recruitment to sustain growth.

**【CEO Summary Section】**
- **Q2 2026 Financial Highlights**: Revenue of $659 million (+15% YoY), Adjusted EPS of $1.84 (+26% YoY). Corporate Finance revenue up 21% to $439 million, driven by 171 transactions (vs. 131 last year). Backlog suggests strong Q4 CF performance, breaking seasonal trends.\n- **Segment Growth**:\n  - **Financial Restructuring**: $134 million (+2% YoY), 37 transactions (vs. 33 last year).\n  - **FDA**: $87 million (+10% YoY), 1,075 fee events (+19%).\n  - **International Expansion**: EMEA and APAC regions show solid growth, with 5 new MD hires.\n- **Strategic Initiatives**: Active acquisition pipeline and talent recruitment to sustain momentum.\n\n**【CFO Financial Commentary】**\n- **Expense Management**: Adjusted compensation expense ratio 61.5% (flat YoY), non-compensation expenses $2 million (down 97% YoY).\n- **Balance Sheet Strength**: $1.1 billion cash, 210,000 shares repurchased Q2. Deferred bonuses (~$18 million) to be paid in November.\n- **Tax Efficiency**: 29.7% effective tax rate (down 1.6pts YoY).\n\n**【Q&A Key Highlights】**\n- **Restructuring Trends**: Backlog remains robust despite slower new business, with episodic shocks (e.g., alcohol sector stress).\n- **Sponsor Activity**: Consistent engagement since Q1, with Q4 deal timing accelerating.\n- **FDA Growth**: 30-70% cyclical sensitivity vs. CF, with non-cyclical PV business driving consistency.\n- **International Strategy**: EMEA/Asia CF growth outpaces U.S., targeting Europe fee pool parity with U.S.\n- **Share Repurchases**: Focused on minimizing dilution, with opportunistic buys based on cash availability.

Houlihan Lokey, Inc. (HLI) Q2 2026 Earnings Call Transcript

- **Revenue Growth**: 18% YoY to $605M, EPS up 75% to $2.14, driven by all 3 business lines.
- **Market Momentum**: Cautious optimism on improving M&A, with post-Labor Day pickup in sponsor activity.
- **Restructuring Resilience**: Elevated through FY26, despite rate cuts, due to liability management work.
- **Cost Management**: Compensation ratio stable at 61.5%, non-comp growth 18% Q1 vs. high single-digit full year target.
- **Geographic Split**: U.S. outpaces EMEA, with EMEA lagging due to macro uncertainty.
- **ONE Conference Impact**: Showcased 'one firm' strategy, with 4,000 attendees and 400 companies participating.


**【CEO Summary Section】**
- Q1 2026 revenue of $605 million, up 18% YoY; adjusted EPS of $2.14, up 75% YoY.
- **Corporate Finance**: $399M revenue (+21% YoY), driven by 125 transactions and higher fee per transaction. U.S. outpaces EMEA, with cautious optimism on sponsor activity post-Labor Day.
- **Financial Restructuring**: $128M revenue (+9% YoY), supported by high interest rates and overleveraged companies. Balanced debtor/creditor mix.
- **Financial & Valuation Advisory**: $79M revenue (+16% YoY), growth in non-cyclical services and improving U.S. M&A.
- **ONE Conference**: 4,000 attendees, 400 companies, showcasing 'one firm' approach.
- Global reach and diversified model position the company to navigate macro volatility.

**【CFO Financial Commentary】**
- **Revenues**: 
  - Corporate Finance: $399M (+21% YoY), 125 transactions vs. 116 last year.
  - Restructuring: $128M (+9% YoY), 35 transactions vs. 33 last year.
  - FVA: $79M (+16% YoY), 957 fee events vs. 847 last year.
- **Expenses**: 
  - Adjusted compensation: $372M (+18% YoY), 61.5% ratio (target range).
  - Non-compensation: $94M (+18% YoY), driven by ONE Conference costs.
- **Tax Rate**: -0.8% Q1 FY26 vs. 31.2% Q1 FY25, due to exclusion of stock vesting impact. Full year 2026 tax rate expected 25-26%.
- **Balance Sheet**: $867M cash, down due to FY25 bonuses and share issuance.

**【Q&A Highlights】**
- **Market Momentum**: CEO notes 'quarter-by-quarter improvement' but 'not month-by-month.' Clients adapting to volatility.
- **Sponsor Activity**: Muted but 'picking up,' with expectations for acceleration post-Labor Day.
- **Restructuring Outlook**: Elevated through FY26, resilient despite rate cuts (e.g., liability management work).
- **Hiring Strategy**: Senior MD hiring reflects opportunistic talent acquisition, not structural shift.
- **Non-Comp Growth**: CFO reaffirms high single-digit YoY growth target, driven by headcount expansion.
- **Geographic Trends**: U.S. M&A outpacing EMEA, with EMEA lagging due to 'cycle time' differences.
- **Tariffs/Risks**: Management acknowledges tariffs and inflation as headwinds but focuses on diversified model resilience.


Houlihan Lokey, Inc. (HLI) Q1 2026 Earnings Call Transcript

- **Record Growth**: Q4 2025 revenue up 28% YoY, FY 2025 revenue hits $2.4B (+25% YoY)
- **Strategic Acquisitions**: 3 deals in FY 2025 drive global expansion and product diversification
- **Restructuring Resilience**: Q4 revenue up 6% YoY, capacity for 40%+ growth in stressed markets
- **Non-US Momentum**: Transaction size and fees rising, 4 MD hires in Q4
- **Dividend Boost**: 5.3% increase to $0.60/share, reflecting strong cash position

**【CEO Key Highlights】**
- Q4 2025 Revenue: $666 million (+28% YoY), Adjusted EPS: $1.96 (+54% YoY)
- FY 2025 Record Revenue: $2.4 billion (+25% YoY), driven by Financial Restructuring (+6% Q4 YoY) and Capital Solutions rebranding
- Strategic Acquisitions: 3 deals in FY 2025, expanding global reach and product offerings
- Non-US Growth: Average transaction size and fees rising, 4 Managing Director hires in Q4
- FY 2026 Outlook: Momentum across all lines despite market volatility, restructuring poised for elevated activity

**【CFO Financial Breakdown】**
- **Corporate Finance**: $413M (+44% YoY), 147 transactions (vs. 121 last year), seasonal Q4 decline expected
- **Financial Restructuring**: $165M (+6% YoY), 38 transactions (vs. 35 last year), strong Q4 close
- **FDA**: $89M (+15% YoY), 1,224 fee events (vs. 1,025 last year)
- **Compensation Ratio**: 61.5% (stable vs. prior year), $410M adj. comp expense
- **Non-Comp Expense**: $85M (12.8% ratio), $32K/employee vs. $31K last year
- **Tax Rate**: 24.5% (down from 29.9% YoY), 5.3% dividend increase to $0.60/share

**【Q&A Key Takeaways】**
- **Market Volatility**: Deal activity steady, but bifurcation by geography/sector (e.g., industrials vs. non-US)
- **Restructuring Outlook**: Elevated levels expected, capacity for 40%+ revenue/MD growth in stressed scenarios
- **Capital Solutions**: 50% of client base remains financial sponsors, continuation funds driving activity
- **Acquisition Pipeline**: Active deal flow, focus on white space in alternative capital solutions
- **FY 2026 Seasonality**: Similar to FY 2025, with Q4 restructuring strength expected

Houlihan Lokey (HLI)-7 May 25-2025 Q4 Earnings call transcript

- **Revenue Growth**: Q3 FY2025 revenue up 24% YoY to $634M, driven by 36% growth in Corporate Finance.
- **Resilient Restructuring**: $131M in Q3 despite M&A recovery, supported by high interest rates.
- **Cost Efficiency**: Compensation ratio stable at 61.5%, non-comp expense ratio down to 13.1%.
- **Positive Outlook**: FY2026 expected to benefit from M&A recovery, private equity activity, and sustained restructuring demand.
- **Market Trends**: Deal velocity improving but not yet pre-pandemic levels; sponsor M&A activity accelerating.

**【CEO Opening Remarks】**
- Q3 FY2025 revenue: $634 million (+24% YoY), adjusted EPS: $1.64 (+34% YoY). 
- **Corporate Finance**: $422M (+36% YoY), driven by 170 transactions vs 117 last year. Close rates, time-to-close, and transaction volume all improved.
- **Financial Restructuring**: $131M (+2% YoY), maintained backlog with 41 transactions.
- **FVA**: $82M (+14% YoY), benefiting from improving M&A climate.
- Acquired Waller Helms, adding 17 MDs (14 via acquisition, 3 hires). Outlook for FY2026: positive with M&A recovery, PE activity, and restructuring strength.

**【CFO Financial Details】**
- **Compensation Expense**: $390M (61.5% ratio vs 61.5% last year), stable target maintained.
- **Non-Comp Expense**: $83M (+1% YoY), 13.1% ratio vs 16.1% last year. Per-employee cost: $31K (flat YoY).
- **Tax Rate**: 33.3% (vs 30.3% last year), FY2025 expected 31-32%.
- **Cash Position**: $903M, with $300M+ expected for FY2025 bonuses.

**【Q&A Key Takeaways】**
1. **Market Trends**: 
   - Corporate Finance growth steady at ~24% YoY, consistent with past quarters.
   - Restructuring resilient despite M&A recovery, driven by high interest rates and leveraged balance sheets.
2. **Competitive Dynamics**: 
   - Mid-market firms performing well; Houlihan focused on mid-cap space with diversified industry exposure.
   - Capital Solutions business sees competition from large banks, but targets different market segments.
3. **Transaction Activity**: 
   - Deal velocity improving but not back to pre-pandemic levels. Sponsor activity picking up, especially in M&A.
   - Restructuring backlog maintained, with no decline expected in current macro environment.
4. **Outlook**: 
   - FY2026 positive with M&A recovery, PE activity, and restructuring strength.
   - Seasonality expected to hold (~46% H1, 54% H2).

HLI

HLI fundamentals

Earnings Call

You can ask Aime